I
The startup develops biopharmaceuticals utilizing next-generation protein degradation mechanisms to target previously undruggable proteins associated with rare diseases. Their approach provides advanced drug candidates for out-licensing or in-licensing opportunities in the global pharmaceutical market.
성남시, 대한민국
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops biopharmaceuticals utilizing next-generation protein degradation mechanisms to target previously undruggable proteins associated with rare diseases. Their approach provides advanced drug candidates for out-licensing or in-licensing opportunities in the global pharmaceutical market.